Skip to main content

Current Status of Antiviral Chemotherapy for Genital Herpes Simplex Virus Infection: Its Impact on Disease Control

  • Chapter
Perspectives in Antiinfective Therapy
  • 36 Accesses

Abstract

Acyclovir is an effective treatment for herpes simplex virus (HSV) infection. Its use produces improvement in symptoms and reduces the frequency of recurring disease. During chronic suppressive acyclovir therapy, breakthrough recurrences and asymptomatic viral shedding are common. Adverse reactions or signs of toxicity from acyclovir have been minimal. Early treatment does not prevent the establishment of latent HSV infection, the transmission of genital HSV infection, or asymptomatic viral shedding. Patient awareness of atypical lesions and modification of sexual activity are important aspects affecting transmission. Acyclovir resistance is being reported with increasing frequency, especially in patients infected with the human immunodeficiency virus. The development of additional antiviral agents would be beneficial in continuing the progress toward control of HSV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Elion, G.: Selectivity of action of an antiherpetic agent 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences of the USA 1977, 74: 5716.

    Article  PubMed  CAS  Google Scholar 

  2. Dorsky, D. I., Crumpacker, C. S.: Drugs 5 years later. Annals of Internal Medicine 1987, 207 (Supplement 6): 859–874.

    Article  Google Scholar 

  3. Pazin, G. H., Harger, J. H., Armstrong, J. A.: Leukocyte interferon for treating first episodes of genital herpes in women. Journal of Infectious Diseases 1987, 156: 891–898.

    Article  PubMed  CAS  Google Scholar 

  4. Mindel, A., Kinghorn, G., Allison, J. E.: Treatment of first attack genital herpes, acyclovir versus Inosine Pranobex. Lancet 1987, i: 1171–1173.

    Article  Google Scholar 

  5. Sacks, S. L., Portnoy, J., Loweed, D.: Clinical course of recurrent genital herpes and treatment with foscarnate: results of a Canadian multicenter trial. Journal of Infectious Diseases 1987, 155: 178–186.

    Article  PubMed  CAS  Google Scholar 

  6. Corey, L., Adams, H. G., Brown, Z. A., Holmes, K. K.: Genital herpes simplex virus infection: clinical manifestations, course and complications. Annals of Internal Medicine 1983, 98: 958–972.

    Article  PubMed  CAS  Google Scholar 

  7. Bryson, Y. J., Dillon, M., Lovett, M., Acuma, G., Taylor, S., Cherry, J. D., Johnson, B. L., Wiesmeier, E., Growdon, W., Creagh-Kirk, T., Keeney, R.: Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir; a randomized double blind controlled trial in normal subjects. New England Journal of Medicine 1983, 308: 916–921.

    Article  PubMed  CAS  Google Scholar 

  8. Corey, L., Benedetti, J., Critchlow, C., Mertz, C., Douglas, J., Fife, K., Fahnlander, A., Remington, M. L., Winter, C., Dragavon, J.: Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous, and oral therapy. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 79–88.

    Article  PubMed  Google Scholar 

  9. Corey, L., Fife, K. H., Benedetti, J. K., Winter, C. A., Fahnlander, A., Conner, J. D., Hintz, M. A., Holmes, K. K.: Intravenous acyclovir for the treatment of primary genital herpes. Annals of Internal Medicine 1983, 98: 914–921.

    Article  PubMed  CAS  Google Scholar 

  10. Fiddian, A. P., Kinghorn, G. R., Goldmeier, D., Reese, E., Rodin, P., Thin, R. N. T., deKonig, G. A. J.: Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 67–77.

    Article  PubMed  Google Scholar 

  11. Mertz, G. J., Critchlow, C. W., Benedetti, J., Reichman, R. C., Dolin, R., Connor, J., Redfield, D. C., Savoia, M. C., Richman, D. D., Tyrell, D. L., Miedzinski, L., Portnoy, J., Keeney, R. E.: Double blind placebo controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. Journal of the American Medical Association 1984, 252: 1147–1151.

    Article  PubMed  CAS  Google Scholar 

  12. Mindel, A., Adler, M. W., Sutherland, S., Fiddian, A. P.: Intravenous acyclovir treatment for primary genital herpes. Lancet 1982, i: 697–700.

    Article  Google Scholar 

  13. Nilsen, A. E., Aasen, T., Halsos, A. M., Kinge, B. R., Tjotta, E. A. L., Wilkstrom, K., Fiddian, A. P.: Efficacy of oral acyclovir in treatment of initial and recurrent genital herpes. Lancet 1982, ii: 572–573.

    Google Scholar 

  14. Thin, R. N., Nabarro, J. M., Parker, J. D., Fiddian, A. P.: Topical acyclovir in the treatment of initial genital herpes. British Journal of Venereal Disease 1983, 59: 116–119.

    CAS  Google Scholar 

  15. Mindel, A., Weiler, I. V. D., Faherty, A., Sutherland, S., Fiddian, A. P., Adler, M. W.: Acyclovir in first attacks of genital herpes and prevention of recurrences. Genitourinary Medicine 1986, 62: 28–32.

    PubMed  CAS  Google Scholar 

  16. Corey, L., Benedetti, J. K., Critchlow, C. W., Remington, M. L., Winter, C. A., Fahnlander, A. L., Smith, K., Salter, D., Keeney, R. E., Davis, L. G., Hintz, M. A., Conner, J. D., Holmes, K. K.: Double blind controlled trial of topical acyclovir in genital herpes simplex virus infections. American Journal of Medicine 1982, 73 (Supplement 1A): 326–334.

    Article  PubMed  CAS  Google Scholar 

  17. Reichman, R. C., Badger, G. J., Mertz, G. J., Corey, L., Richman, D. D., Connor, J. D., Redfield, D., Savoia, M. C., Oxman, M. N., Bryson, Y., Tyrrell, D. L., Portnoy, J., Creigh-Kirk, T., Keeney, R. E., Ashikaga, T., Dolin, R.: Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. Journal of the American Medical Association 1984, 251: 2103–2107.

    Article  PubMed  CAS  Google Scholar 

  18. Douglas, J. M., Critchlow, C., Benedetti, J., Mertz, G. J., Conner, J. D., Hintz, M. A., Fahnlander, A., Remington, M., Winter, C., Corey, L.: A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. New England Journal of Medicine 1984, 310: 1551–1556.

    Article  PubMed  CAS  Google Scholar 

  19. Halsos, A. M., Salo, O. P., Lassus, A., Tjotta, E. A. L., Havi, T., Gabrielsen, B., Fiddian, A. P.: Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled crossover study. Acta Dermato-Venereologica 1985, 65: 59–63.

    PubMed  CAS  Google Scholar 

  20. Mindel, A., Faherty, A., Hindley, D., Adler, M. W., Weller, I. V. D., Sutherland, S., Fiddian, A. P.: Prophylactic oral acyclovir in recurrent genital herpes. Lancet 1986, ii: 57–59.

    Google Scholar 

  21. Straus, S. E., Takiff, H. E., Mindell, S., Seidlin, M., Bachrach, S., Lininger, L., DiGiovanna, J. J., Western, K. A., Smith, H. A., Nusinoff-Lehrman, S., Creagh-Kirk, T., Alling, D.W.: Suppression of frequently recurring genital herpes; a placebo controlled double blind trial of oral acyclovir. New England Journal of Medicine 1984, 310: 1545–1550.

    Article  PubMed  CAS  Google Scholar 

  22. Mindel, A., Faherty, A., Carney, O., Patou, G., Freris, M., Williams, P.: Long term suppressive acyclovir therapy — dosage and safety in patients with recurrent genital herpes. Lancet 1988, i: 926–928.

    Article  Google Scholar 

  23. Mertz, G., Jones, C., Mills, J., Fife, K. H., Lemon, S., Stapleton, J. T., Hill, E. L., Davis, L. G., and the Acyclovir Study Group: Long term acyclovir suppression of frequently recurring genital herpes simplex virus infection: a multicenter double blind trial. Journal of the American Medical Association 1988, 260 (Supplement 2): 201–206.

    Article  PubMed  CAS  Google Scholar 

  24. Rooney, J. F., Felser, J. M., Ostrove, J. M., Strause, S. E.: Acquisition of genital herpes from an asymptomatic sexual partner. New England Journal of Medicine 1986, 34: 1561–1564.

    Article  Google Scholar 

  25. Tucker, W. E.: Preclinical toxicology of acyclovir: an overview. American Journal of Medicine, Acyclovir Symposium, 1982, p. 27–30.

    Google Scholar 

  26. Douglas, J. M., Davis, L. G., Remington, M. L., Paulsen, C. A., Perrin, E. B., Goodman, P., Conner, J. D., King, D., Corey, L.: A double-blind placebo-controlled trial of the effect of chronic oral acyclovir on sperm production in men with frequently recurrent genital herpes. Journal of Infectious Diseases 1988, 157: 588–593.

    Article  PubMed  Google Scholar 

  27. Gold, D., Corey, L.: Acyclovir prophylaxis for herpes simplex virus infection. Antimicrobial Agents and Chemotherapy, 1987, 361–367.

    Google Scholar 

  28. Straus, S. E., Seidlin, M., Takiff, H. E., Rooney, J. F., Nusinoff-Lehrman, S., Bachrach, S., Felser, J. M., Giovanna, J. J., Grimes, G. J., Krakauer, H., Hallanan, C., Alling, D.: Double blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Research 1986, 6: 151 – 159.

    Article  PubMed  CAS  Google Scholar 

  29. Shepp, D. H., Dandliker, P. S., Flournoy, N., Meyers, J. D.: Once-daily intravenous acyclovir tor prophylaxis of herpes simplex virus reactivation after marrow transplantation. Journal of Antimicrobial Chemotherapy 1985, 16: 389–395.

    Article  PubMed  CAS  Google Scholar 

  30. Brown, Z. A., Vontver, L. A., Benedetti, J., Critchlow, C. W., Sells, C. J., Berry, S., Corey, L.: Effects on the infants of first episode genital herpes during pregnancy. New England Journal of Medicine 1987, 317: 1247–1251.

    Article  Google Scholar 

  31. Lagrew, D. C., Furlow, T. G., Hager, D., Yarrish, D. L.: Dissemianted herpes simplex virus infection in pregnancy: succesful treatment with acyclovir. Journal of the American Medical Association 1984, 252: 2038–2039.

    Article  Google Scholar 

  32. Coen, D. M., Schaffer, P. A.: Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proceedings of the National Academy of Sciences of the USA 1980, 77: 2265–2269.

    Article  PubMed  CAS  Google Scholar 

  33. Crumpacker, C. S., Schnipper, L. E., Marlowe, S. I., Kowalsky, P. N., Hershey, B. J., Levin, M. J.: Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. New England Journal of Medicine 1982, 306: 343–346.

    Article  PubMed  CAS  Google Scholar 

  34. Barry, D. W., Lehrman, S. N., Ellis, M. N.: Clinical and laboratory experience with acyclovir-resistant herpesviruses. Journal of Antimicrobial Chemotherapy 1986, 18 (Supplement B): 75–84.

    PubMed  Google Scholar 

  35. Dekker, C., Ellis, M. N., McLaren, C., Hunter, G., Rogers, J., Barry, D. W.: Virus resistance in clinical practice. Journal of Antimicrobial Chemotherapy 1983, 12 (Supplement B): 137–152.

    Article  PubMed  Google Scholar 

  36. Burns, W. H., Santos, G. W., Leitman, P. S., Sarai, R., Laskin, O. L., McLaren, C., Barry, D.W.: Isolation and characterization of resistant herpes simplex virus after acylcovir therapy. Lancet 1982, i: 421–423.

    Article  Google Scholar 

  37. Field, H. J., Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrobial Agents and Chemotherapy 1980, 17: 209–216.

    Article  PubMed  CAS  Google Scholar 

  38. Parris, D. S., Harrington, J. E.: Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrobial Agents and Chemotherapy 1982, 22: 71–77.

    Article  PubMed  CAS  Google Scholar 

  39. McLaren, C., Corey, L., Dekker, C., Barry, D. W.: In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir treated patients. Journal of Infectious Diseases 1983, 148: 868–875.

    Article  PubMed  CAS  Google Scholar 

  40. Meyers, J. D.: Treatment of herpesvirus infections in the immunocompromised host. Scandinavian Journal of Infectious Disease 1985, Supplement 47: 128–136.

    Google Scholar 

  41. Nusinoff-Lehrman, S., Douglas, J. M., Corey, L., Barry, D. W.: Recurrent genital herpes and suppressive oral acyclovir therapy: relationship between clinical outcome and in vitro drug sensitivity. Annals of Internal Medicine 1986, 104: 786–790.

    Article  Google Scholar 

  42. Division of Sexually Transmitted Diseases, Center for Prevention Services, Centers for Disease Control: Genital herpes infection — United States, 1966–1984. Morbidity and Mortality Weekly Report 1986, 35: 402–404.

    Google Scholar 

  43. Chuang, T.Y., Su, W. P. D., Perry, H. O., Ilstrup, D. M., Kurland, L. T.: Incidence and trend of herpes progenitalis: a 15 year population study. Mayo Clinic Proceedings 1983, 58: 436–441.

    PubMed  CAS  Google Scholar 

  44. Sullivan-Bolyai, J., Hull, H. F., Wilson, C., Corey, L.: Neonatal herpes simplex virus infections in King County, Washington, Journal of the American Medical Association 1983, 250: 3059–3062.

    Article  PubMed  CAS  Google Scholar 

  45. Corey, L., Spear, P. G.: Infections with herpes simplex viruses. Parts I and II. New England Journal of Medicine 1986, 314: 686–691.

    Article  PubMed  CAS  Google Scholar 

  46. Corey, L., Spear, P. G.: Infections with herpes simplex viruses. Parts I and II. New England Journal of Medicine 1986, 314: 749–757.

    Article  PubMed  CAS  Google Scholar 

  47. Stevens, J. G., Wagner, E. K., Rao, G. B., Cook, M. L., Feldman, L. T.: RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235: 1056–1059.

    Article  PubMed  CAS  Google Scholar 

  48. Croen, K. D., Ostrove, J. M., Dragovic, L. J., Smialek, J. E., Straus, S. E.: Latent herpes simplex virus in human trigeminal gnaglia: detection of an immediate early gene “anti-sense” transcript by in situ hybridization. New England Journal of Medicine 1987, 317: 1427–1432.

    Article  PubMed  CAS  Google Scholar 

  49. Mertz, G. J., Schmidt, O., Jourden, J. L., Guinan, M. E., Remington, M. L., Fahnlander, A., Winter, C., Holmes, K. K., Corey, L.: Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sexually Transmitted Diseases 1985, 12: 33–39.

    Article  PubMed  CAS  Google Scholar 

  50. Mertz, G. J., Coombs, R. W., Ashley, R., Jourden, J., Remington, M., Winter, C., Fahnlander, A., Guinan, M., Ducey, H., Corey, L.: Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. Journal of Infectious Diseases 1988, 157: 1169–1177.

    Article  PubMed  CAS  Google Scholar 

  51. Moore, D.E., Zarutskie, P. W., Soules, M. R., Ashley, R., Dragavon, J., Remington, M., Corey, L.: Transmission of genital herpes by artificial insemination with a donor experiencing asymptomatic primary HSV-2 infection. Journal of the American Medical Association (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

G. G. Jackson H. D. Schlumberger H. J. Zeiler

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Corey, L. (1989). Current Status of Antiviral Chemotherapy for Genital Herpes Simplex Virus Infection: Its Impact on Disease Control. In: Jackson, G.G., Schlumberger, H.D., Zeiler, H.J. (eds) Perspectives in Antiinfective Therapy. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-322-86064-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-322-86064-4_29

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-528-07979-6

  • Online ISBN: 978-3-322-86064-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics